A prototype Protein A resin is evaluated for purification performance, reusability, and cost performance.
Yasufumi Ueda
Advertisement
Yasufumi Ueda is in the API process development department, Pharmaceutical Technology Division, Chugai Pharmaceutical, Tokyo, Japan.
Articles by Yasufumi Ueda
Advertisement
Latest Updated Articles
Comparing Protein A Resins for Monoclonal Antibody PurificationPublished: December 1st 2013 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
